key: cord-1001691-2qp4ahvo authors: Jafarian, Hadis; Gharaghani, Maral; Seyedian, Seyed Saeed; Mahmoudabadi, Ali Zarei title: Genotyping, antifungal susceptibility, enzymatic activity, and phenotypic variation in Candida albicans from esophageal candidiasis date: 2021-05-14 journal: J Clin Lab Anal DOI: 10.1002/jcla.23826 sha: 51595b3428f11693797830bc3286a9fd39d06eb0 doc_id: 1001691 cord_uid: 2qp4ahvo BACKGROUND: Esophageal candidiasis is the most frequent form of esophagitis. The pathogenicity of Candida spp. is related to a combination of microbial factors, hydrolytic enzyme secretion and phenotypic switching. This study was designed to investigate esophageal candidiasis, antifungal activity, enzymatic activity patterns, phenotyping, and genotyping profiles of Candida albicans species. METHODS: Nine hundred thirty‐three visited patients were evaluated, and esophageal biopsies from patients were included in this study during 2019–2020. Direct smear, Gram staining, and culture on CHROMagar were performed for each sample. Isolated species were identified with conventional procedures and PCR‐RFLP. Susceptibility to antifungals was determined according to CLSI guidelines. ABC typing, phenotype switching, hemolysin, proteinase, phospholipase, and esterase activity were also determined with the appropriate protocols. RESULTS: Twenty‐three (2.5%) patients (mean age 55.2 years) were diagnosed with esophageal candidiasis. The species isolated were 19(82.6%) C. albicans, 3(13.1%) C. glabrata, and 1(4.3%) C. tropicalis. Genotype A (57.9%) was the predominant type in C. albicans isolates. 50% of C. albicans isolates exhibited a white phenotype. A high level of phospholipase (47.4%), hemolysin (68.4%), and proteinase activity (36.8%) was observed in the C. albicans isolates. Only three C. glabrata isolates displayed non‐wild type susceptibility to voriconazole and itraconazole. CONCLUSION: This study shows that C. albicans are still the most frequent isolates from patients with esophageal candidiasis. The predominance of genotype A, the white phenotype, and strong hemolysin activity may indicate a high prevalence of pathogenicity in these isolates. Sensitivity to antifungal drugs was greatest for amphotericin and fluconazole. Candidiasis is a yeast infection with worldwide distribution. Although superficial forms of the disease are benign, deep forms of candidiasis are life-threatening, especially in immunocompromised patients. Candida spp. are common opportunistic pathogens originating from the mycobiota of human mucosal sites such as the oropharynx, esophagus, and vagina. 1, 2 The yeast takes advantage of an impaired immune system, which allows proliferation in the esophageal mucosa in the form of adhesive plaques. 3, 4 Esophageal candidiasis is the most frequent form of infectious esophagitis and is usually common among patients infected with the human immunodeficiency virus. 5, 6 The prevalence of esophageal candidiasis ranges from up to 5.2% in the general population to 9.8% in HIV-positive patients. 7, 8 Associated risk factors reported to date include increasing age, HIV infection, use of antibiotics, herbal medication, heavy drinking, and high-dose corticosteroids. 8, 9 The pathogenicity of Candida spp. is related to a combination of microbial factors such as their ability to grow at 37°C, polymorphism, biofilm formation, hydrolytic enzyme secretion, and phenotypic switching. [10] [11] [12] Candida spp. can secrete lipolytic enzymes such as esterase and phospholipase. The secretion of phospholipases can disrupt phospholipids in the host mucosal epithelium, which is a major constituent of cell membranes. 13 Esterase activity is also useful in differentiating some Candida spp. 14 Clinical Candida isolates produce considerably more hemolysin than environmental isolates. 15 About ten proteinase isoenzymes with various functions have been described in Candida albicans. Some of them are related to adherence, tissue damage, and changes in the immune response, and increased activity can lead to severe candidiasis. 11 Candida albicans as a major human fungal pathogen [16] [17] [18] [19] can switch between different morphological phenotypes. Histopathological examination in a murine model demonstrated the presence of pseudohyphae and C. albicans yeasts in kidney tissue. 20 The best described fungal phenotype switch is the white-to-opaque transition. 21 Different cell types vary in certain features including cell and colony appearance, mating, adherence, enzyme secretion, and their susceptibility to antifungals. 22, 23 A reproducible and discriminatory strain typing system for C. albicans is beneficial for clinical and epidemiological studies, because it can provide useful information especially on properties such as virulence and antimicrobial resistance. ABC genotyping is a reproducible and straightforward method of strain typing for C. albicans. It is valuable for primary clinical and epidemiological studies because it provides information especially on the relations between strain types and properties such as virulence and antimicrobial resistance. According to this method, C. albicans is divided into several genotypes based on the electrophoresis banding pattern, for example, A, B, C, D, and E. 24, 25 In oral, vulvovaginal, and nail samples, the A genotype was the predominant type in previous studies. [26] [27] [28] According to the guidelines of the Infectious Diseases Society of America (IDSA), antifungal treatment for Candida infections is restricted to three major classes of antifungal drugs: azoles, polyenes, and echinocandins. 29 Although antifungal resistance in C. albicans is less frequent than in other species, an increasing number of resistant strains are emerging. 22, 30 However, despite the profusion of data on antifungal susceptibility patterns of C. albicans, there is only limited information on the association between enzymatic activity, phenotypic variation, and antifungal susceptibility. [30] [31] [32] This study was designed to investigate etiologic agents of esophageal candidiasis, their antifungal susceptibility profiles, virulence patterns including enzymatic activity (phospholipase, protease, esterase, and hemolysin), phenotype variations, and genotyping methods for C. albicans isolates. The present cross-sectional study was carried out in the depart- Antifungal susceptibility testing was done according to CLSI M27 4th edition. 36 Briefly, all isolates were cultured on Sabouraud dextrose agar (SDA) (Pronadisa, Spain) before susceptibility testing to ensure purity and viability. Yeast inoculum was prepared by suspending colonies of each isolate from an overnight culture in sterile distilled water, and suspensions were adjusted to a turbidity of 0.5 McFarland standard to obtain 1 × 10 6 to 5 × 106 CFU/ml. Antifungal Isolates that exhibited trailing in response to fluconazole were eval- Proteinase production was evaluated on medium containing 1 g Phospholipase production was visualized in egg yolk agar plates as described by Samaranayake et al 41 The medium consisted of 65 g SDA, 4.58 g NaCl (Mojallali Chemical Laboratory), and 5.5 g CaCl 2 (Merckl in 920 ml distilled water. The medium was sterilized, and TA B L E 1 ABC genotype, antifungal susceptibility profile, enzymatic activity, and phenotype switching of isolated yeasts after cooling, it was supplemented with 80 ml egg yolk added to the medium. The plates were incubated at 37°C, and the diameters of the colonies with the zones of precipitation were measured after seven days of incubation. The medium to evaluate esterase activity was prepared as described by Slifkin 14 with 10.0 g Bacto Peptone, 5.0 g NaCl, 0.1 g CaCl 2 , 15.0 g agar (Mirmedia), and 1000 ml distilled water. The medium was autoclaved and cooled to about 50°C, and then, 5 ml autoclaved Tween 80 was added. The plates were inoculated and then incubated at 30°C and were examined daily for 10 days. Hemolysin activity was evaluated with blood agar plates prepared as described by Negri et al. 15 Sabouraud dextrose agar was supplemented with 3% glucose and 7% sheep blood (Baharafshan). The plates were inoculated and incubated at 37°C for five days. Positive hemolysin activity was demonstrated as a ring of lysis around the colonies. Figure 1 ). Nine C. albicans isolates exhibited white colonies on YPD agar medium containing phloxine B. Five C. albicans isolates produced gray colonies. We observed a combination of white-gray colonies in four C. albicans isolates, and white-opaque colonies in one isolate. There were no significant differences between genotypes in the frequency of phenotype switching (p ≤ 0.232) ( Table 1 ). A high level of phospholipase activity was observed in nine 50 and MIC 90 values could not be calculated because of the small number of isolates (<10). were strong phospholipase producers. Very strong hemolysin and proteinase activity was seen in 13 (68.4%) and seven (36.8%) C. albicans strains, respectively. Eighteen (94.7%) C. albicans strains presented very strong esterase activity with a mean value of 0.39. There were no significant differences between genotypes in the frequency of hemolysin (p ≤ 0.8), proteinase (p ≤ 0.1), or phospholipase activity (p ≤ 0.4), whereas a significant difference between genotypes was found for esterase activity, with p ≤ 0.04 (Table 3 ). Esophageal candidiasis is an opportunistic infection frequently reported in immunocompromised patients, although a higher occurrence was also reported in the immunocompetent population with underlying conditions. 42 Once host protection mechanisms are compromised, Candida can proliferate on the esophageal mucosa and form adherent white to yellowish plaques. In a case-control study of patients with esophageal candidiasis (≥65 years old) a 6-month mortality rate of 47% compared to 5% in controls 43 was reported. In some rare cases, esophageal candidiasis may result in hemorrhagic esophageal ulcers, 44 invasive candidiasis, 45 and esophageal squamous cell carcinoma. 46 In the present study, the prevalence of esophageal candidiasis was 2.4%. The occurrence rate of esophageal candidiasis ranged from 0.0007% to 5.6% in previous inquiries. 8, 42, 43, [47] [48] [49] The preva- According to our findings, the most frequent isolate was C. albicans (82%) followed by C. glabrata (13%), which was in line with other studies. 48, 51, 52 We found no reports about the ABC genotyping of C. albicans isolates from esophageal specimens. Therefore, the closest reports were related to isolates from mucosal sites and the oral cavity. We found all three types (A, B, and C) of C. albicans in our study, and genotype A was the predominant one. We also found 2 isolates belonging to genotype C. In contrast, according to the study by Sardi activity. These authors also noted that white colonies were more virulent than gray and opaque colonies. 23 In line with their study, most of the gray colonies in the present study had strong or very strong proteinase activity. In contrast, about half of our C. albicans isolates had no or only mild proteinase activity. Also, most of the C. albicans isolates in our study were white, that is, the phenotype that was most virulent in the ex vivo study by Tao et al.. 23 In this connection, we note that phenotype switching over generations in five of our isolates did not affect trailing. In conclusion, there is limited information about the characteristics of etiologic agents of esophageal candidiasis or yeast factors operative in the pathogenesis of esophageal candidiasis, and in vivo experiments are scarce. The prevalence of esophageal candidiasis varies in different studies due to differences in study populations and predisposing factors. We found no resistance among our C. albicans isolates to selected antifungals, but because of the low number of isolates studied here, there is a need for larger studies. However, all three C. glabrata isolates remained non-wild type for voriconazole and itraconazole resistance. New antifungals such as luliconazole may be an effective alternative in cases of antifungal resistance, and further in vivo studies should be done. The predominance of genotype A, the white phenotype, and strong hemolysin activity may indicate a high prevalence of pathogenicity in these isolates. The present study had some limitations. Because of the COVID-19 pandemic, sampling was limited and the number of isolates available for analysis was consequently low. We suggest a larger population for further research. Because most of the patients were not hospitalized, we could not investigate their predisposing factors. On the other hand, the present study is the first, to our knowledge, to determine the frequency of phenotype switching and ABC genotypes in C. albicans as the predominant clinical isolate. The consent documents were signed and dated by the patients. We are thankful to the Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran for providing the funds for this study through grant no. OG-9835. We thank K. Shashok (AuthorAID in the Eastern Mediterranean) for improving the use of English in the manuscript. The authors state that there is no competitive concern of any nature with this manuscript. AZM involved in study design, supervision, data interpretation, and manuscript editing. HJ involved in experimentation, data collection, analysis, literature search, and manuscript writing. MG involved in experimentation, data collection. SSS involved in patient sampling. Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. Oral mucosal fungal infections Pathogenesis of invasive candidiasis A neglected epidemic: fungal infections in HIV/AIDS Candida esophagitis: accuracy of radiographic diagnosis Candida esophagitis: species distribution and risk factors for infection Esophageal candidiasis. Managing an increasingly prevalent infection Challenges to "classic" esophageal candidiasis: looks are usually deceiving Long-term trends in esophageal candidiasis prevalence and associated risk factors with or without HIV infection: lessons from an endoscopic study of 80,219 patients Prevalence and risk factors of esophageal candidiasis in healthy individuals: a single center experience in Korea Candida albicans pathogenicity mechanisms Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options Virulence factors of Candida species Proteinase and phospholipase activity as virulence factors in Candida species isolated from blood Tween 80 opacity test responses of various Candida species Hemolytic activity and production of germ tubes related to pathogenic potential of clinical isolates of Candida albicans Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry Molecular epidemiology and in vitro antifungal susceptibility of candida isolates from women with vulvovaginal candidiasis in northern cities of Khuzestan province, Iran Molecular identification of candida species isolated from women with vulvovaginal candidiasis: brief report Airway colonisation by Candida and Aspergillus species in Iranian cystic fibrosis patients Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model White-opaque transition": a second high-frequency switching system in Candida albicans Candida commensalism and virulence: the evolution of phenotypic plasticity Discovery of a "white-gray-opaque" tristable phenotypic switching system in candida albicans: roles of non-genetic diversity in host adaptation Molecular epidemiology of the global and temporal diversity of Candida albicans Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea Genotyping and fluconazole susceptibility of Candida albicans strains from patients with vulvovaginal candidiasis in Jos Phenotypic and genotypic variations in Candida albicans isolates from Romanian patients Genotype analysis of clinical Candida albicans isolates using PCRs targeting 25S rDNA and ALT repeat sequences of the RPS and antifungal susceptibility in Ouagadougou Guidelines for treatment of candidiasis High-frequency switching of colony morphology in Candida albicans Fungal morphogenesis and virulence Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode Extraction of genomic DNA from yeasts for PCR-based applications A oneenzyme PCR-RFLP assay for identification of six medically important Candida species Amplification and direct sequencing of fungal ribosomal RNA Genes for phylogenetics. PCR protocols: a guide to methods and applications Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement. CLSI document M27-S4. Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500 Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, 4th edn. CLSI standard M27 Epidemiological cutoff values for antifungal susceptibility testing. CLSI supplement M59, 2nd edn The prevalence and clinical significance of microcolonies when tested according to contemporary interpretive breakpoints for fluconazole against Candida species using E-test The frequency, antifungal susceptibility and enzymatic profiles of Candida species isolated from neutropenic patients Factors affecting the phospholipase activity of Candida species in vitro Course of esophageal candidiasis and outcomes of patients at a single center A study of candida esophagitis in elderly patients attending a district general hospital in the UK Refractory hemorrhagic esophageal ulcers by Candida esophagitis with advanced systemic sclerosis Invasive esophageal candidiasis with chronic mediastinal abscess and fatal pneumomediastinum Association of esophageal candidiasis and squamous cell carcinoma A retrospective study of esophageal candidiasis in Jordan, a non-HIV endemic area Molecular identification of Candida species isolated from gastro-oesophageal candidiasis in Tehran. Iran Predictors of esophageal candidiasis among patients attending endoscopy unit in a tertiary hospital, Tanzania: a retrospective cross-sectional study azole antifungal resistance in Candida albicans and emerging non-albicans Candida species Speciation and antifungal susceptibility of esophageal candidiasis in cancer patients in a tertiary care hospital in South India Isolation of Candida species from gastroesophageal lesions among pediatrics in Isfahan, Iran: Identification and Antifungal susceptibility testing of clinical isolates by E-test Genetic and phenotypic evaluation of Candida albicans strains isolated from subgingival biofilm of diabetic patients with chronic periodontitis Molecular phylogenetics of Candida albicans Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and echinocandin resistance Luliconazole, a new antifungal against Candida species isolated from different sources Defining the frontiers between antifungal resistance, tolerance and the concept of persistence Comparative analysis of proteinase, phospholipase, hydrophobicity and biofilm forming ability in Candida species isolated from clinical specimens High detection of virulence factors by Candida species isolated from bloodstream of patients with candidemia Comparative analysis of virulence factors of homozygous and heterozygous strains of Candida albicans vaginal isolates Regulation of phenotypic transitions in the fungal pathogen Candida albicans Passage through the mammalian gut triggers a phenotypic switch that promotes Candida albicans commensalism Genotyping, antifungal susceptibility, enzymatic activity, and phenotypic variation in Candida albicans from esophageal candidiasis